Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A

Publish date:: January 6, 2021

Key clinical point: Mortality rates in the NSHA cohort were influenced by age, male sex, and hepatitis C and HIV infections.

Major finding: The most common primary cause of death was malignancy (20.0%).

Study details: The researchers assessed 6.624 individuals born with NSHA from the ATHNdataset.

Disclosures: Dr. Lim reported no conflicts. Other authors reported research and consulting funding from a variety of pharmaceutical and biotechnology companies.

Citation:

Lim MY et al. Blood Adv. 2020;4(19):4739-47.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,